Yu-fang Huang
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Complement C3 inhibition restores myasthenia gravis AChR antibody-mediated muscle pathophysiology.
Journal: EBioMedicine
Published: December 15, 2025
Cell models for studying myasthenia gravis.
Journal: International review of neurobiology
Published: July 17, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls.
Journal: European journal of neurology
Published: July 14, 2025
On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales.
Journal: Journal of neuromuscular diseases
Published: June 25, 2025
Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients.
Journal: Journal of neuroimmunology
Published: February 17, 2024
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
Journal: iScience
Published: January 05, 2024
Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis.
Journal: Muscle & nerve
Published: December 19, 2023
Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis.
Journal: Muscle & nerve
Published: November 03, 2023
Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs.
Journal: Frontiers in immunology
Published: November 09, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026